The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help ​identify signs of Alzheimer ...

The test is not meant for routine screening but can be pivotal for a diagnosis when cognitive problems are causing doctors to ...

Slow progress often reflects a surface-level relationship with data that already exists, instead of a data shortage.

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.

The new blood test aims to make diagnostic testing more accessible, and therefore easier, so people can get an Alzheimer’s ...

Explore the key differences between dementia and Alzheimer's disease, including symptoms, progression patterns, underlying ...

Ever misplaced your keys and felt a flicker of worry about your brain health? Cognitive decline is something so many of us fear as we age. And while there's no guaranteed way to prevent memory loss, ...

Labcorp (LH) said Monday that its blood test that detects Alzheimer's disease is now available after receiving clearance from the US Food and Drug Administration. The company said its Elecsys pTau-217 ...

Roche’s new blood test can help doctors assess whether amyloid pathology linked to Alzheimer’s disease is likely present.The ...

Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.  | Roche and Eli Lilly have won ...

The blood test is designed to help physicians identify amyloid pathology, a key feature of Alzheimer’s disease, in people ...